Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (24798) 24798
Publication (2006) 2006
Book Review (182) 182
Book Chapter (170) 170
Newspaper Article (48) 48
Conference Proceeding (19) 19
Dissertation (14) 14
Magazine Article (9) 9
Data Set (3) 3
Book / eBook (2) 2
Government Document (2) 2
Web Resource (2) 2
Paper (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15776) 15776
transplantation (15426) 15426
index medicus (10978) 10978
male (10971) 10971
surgery (9770) 9770
female (9559) 9559
immunology (7451) 7451
adult (7410) 7410
middle aged (7259) 7259
allografts (6526) 6526
animals (6307) 6307
kidney transplantation (4587) 4587
recipients (3865) 3865
immunosuppressive agents - therapeutic use (3054) 3054
rejection (3027) 3027
risk factors (3027) 3027
aged (2993) 2993
graft rejection - immunology (2962) 2962
mice (2945) 2945
transplantation, homologous (2942) 2942
retrospective studies (2917) 2917
graft survival (2912) 2912
time factors (2871) 2871
treatment outcome (2845) 2845
immunosuppression (2844) 2844
transplants & implants (2623) 2623
survival (2556) 2556
adolescent (2550) 2550
kidneys (2546) 2546
liver transplantation (2500) 2500
allograft-rejection (2458) 2458
graft rejection (2390) 2390
urology & nephrology (2332) 2332
graft rejection - prevention & control (2176) 2176
allograft recipients (2166) 2166
rats (2141) 2141
liver (2112) 2112
follow-up studies (2086) 2086
analysis (2076) 2076
kidney transplantation - adverse effects (2011) 2011
cyclosporine (1959) 1959
syngeneic grafts (1943) 1943
kidney transplantation - immunology (1862) 1862
child (1825) 1825
allograft (1822) 1822
biopsy (1782) 1782
kidney-transplantation (1729) 1729
renal-allograft recipients (1676) 1676
health aspects (1674) 1674
tissue donors (1639) 1639
disease (1630) 1630
organ transplant recipients (1569) 1569
heart (1546) 1546
heart transplantation (1502) 1502
expression (1495) 1495
acute rejection (1475) 1475
cardiac & cardiovascular systems (1468) 1468
transplantation of organs, tissues, etc (1450) 1450
mice, inbred c57bl (1406) 1406
risk-factors (1403) 1403
medicine (1373) 1373
tolerance (1340) 1340
stem cells (1295) 1295
graft rejection - pathology (1285) 1285
young adult (1276) 1276
therapy (1269) 1269
renal-transplantation (1246) 1246
research (1240) 1240
hematology (1207) 1207
prospective studies (1196) 1196
tacrolimus (1184) 1184
prognosis (1172) 1172
article (1145) 1145
respiratory system (1144) 1144
immunosuppressive agents - adverse effects (1129) 1129
graft survival - immunology (1104) 1104
renal transplantation (1088) 1088
research article (1087) 1087
infection (1077) 1077
lung transplantation (1068) 1068
child, preschool (1064) 1064
mice, inbred balb c (1057) 1057
t-lymphocytes - immunology (1050) 1050
t cells (1030) 1030
acute disease (1027) 1027
gastroenterology & hepatology (1024) 1024
rats, inbred lew (1016) 1016
antibodies (1013) 1013
immunotherapy (1013) 1013
transplant recipients (1006) 1006
t-cells (1001) 1001
mortality (999) 999
kidney (998) 998
survival rate (994) 994
pediatrics (987) 987
immunosuppressive agents - administration & dosage (982) 982
impact (969) 969
allograft survival (963) 963
risk (963) 963
science (961) 961
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24497) 24497
French (170) 170
German (120) 120
Spanish (116) 116
Russian (32) 32
Korean (23) 23
Chinese (17) 17
Japanese (17) 17
Polish (10) 10
Hungarian (8) 8
Portuguese (7) 7
Turkish (4) 4
Persian (2) 2
Italian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: A critical role for recipient CD4+ T cells and recipient leukocyte infusion-derived IFN-γ-producing CD8 + T cells
by Rubio, Marie-Therese and Saito, Toshiki I and Kattleman, Kristin and Zhao, Guiling and Buchli, Jennifer and Sykes, Megan
Journal of Immunology, ISSN 0022-1767, 07/2005, Volume 175, Issue 2, pp. 665 - 676
Surprisingly, antitumor responses can occur in patients who reject donor grafts following nonmyeloablative hemopoietic cell transplantation. In murine mixed... 
MULTIPLE-MYELOMA | NATURAL-KILLER-CELLS | BONE-MARROW-TRANSPLANTATION | ALLOGRAFT TOLERANCE | REFRACTORY HEMATOLOGIC MALIGNANCIES | IMMUNOLOGICAL SELF-TOLERANCE | NKG2D RECEPTOR | IMMUNOLOGY | LYMPHOHEMATOPOIETIC CHIMERISM | MYELOABLATIVE THERAPY | STAGE RENAL-DISEASE | CD8-Positive T-Lymphocytes - transplantation | Lymphoma, B-Cell - therapy | Lymphocyte Depletion | Lymphoma, B-Cell - genetics | Leukemia, B-Cell - therapy | CD4-Positive T-Lymphocytes - immunology | Host vs Graft Reaction - immunology | Lymphocyte Activation - genetics | Interferon-gamma - antagonists & inhibitors | Lymphoma, B-Cell - immunology | CD8-Positive T-Lymphocytes - metabolism | Female | Transplantation Conditioning - methods | Interferon-gamma - deficiency | Leukocyte Transfusion - methods | Radiation Chimera - immunology | Cytotoxicity, Immunologic - genetics | Mice, Inbred C57BL | Down-Regulation - genetics | Mice, Knockout | Host vs Graft Reaction - genetics | Animals | Leukemia, B-Cell - genetics | Down-Regulation - immunology | Cell Line, Tumor | Mice | Mice, Inbred BALB C | Graft Rejection - immunology | CD8-Positive T-Lymphocytes - immunology | Graft Rejection - genetics | Leukemia, B-Cell - immunology | Interferon-gamma - biosynthesis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Multicenter evaluation of efficacy and safety of low‐dose versus high‐dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients
by Heldenbrand, Seth and Li, Chenghui and Cross, Rosemary P and DePiero, Kelly A and Dick, Travis B and Ferguson, Kara and Kim, Miae and Newkirk, Erin and Park, Jeong M and Sudaria‐Kerr, Janice and Tichy, Eric M and Ueda, Kimi R and Weng, Renee and Wisniewski, Jesse and Gabardi, Steven
Transplant Infectious Disease, ISSN 1398-2273, 12/2016, Volume 18, Issue 6, pp. 904 - 912
Background: The cytomegalovirus (CMV) donor-positive/recipient-positive (D+/R+) population is the largest proportion of renal transplant recipients (RTR).... 
valganciclovir | antivirals | cytomegalovirus | prophylaxis | SOLID-ORGAN TRANSPLANTATION | ORAL GANCICLOVIR | INFECTIOUS DISEASES | IMMUNOLOGY | TRANSPLANTATION | CONSENSUS GUIDELINES | IMPACT | KIDNEY-TRANSPLANTATION | 450 MG | PREEMPTIVE GANCICLOVIR THERAPY | INFECTION | MEDICATION ADHERENCE | Follow-Up Studies | Ganciclovir - adverse effects | Immunosuppression - methods | Cytomegalovirus Infections - epidemiology | Humans | Middle Aged | Ganciclovir - analogs & derivatives | Male | Allografts - virology | Transplant Recipients | Incidence | Cytomegalovirus Infections - prevention & control | Graft Rejection - epidemiology | Cytomegalovirus Infections - virology | Ganciclovir - therapeutic use | Adult | Female | Retrospective Studies | Serologic Tests | Cytomegalovirus - isolation & purification | Opportunistic Infections - epidemiology | Antiviral Agents - therapeutic use | Antibiotic Prophylaxis - methods | Treatment Outcome | Antiviral Agents - administration & dosage | Cytomegalovirus Infections - blood | Antiviral Agents - adverse effects | Graft Rejection - immunology | Ganciclovir - administration & dosage | Kidney Transplantation - adverse effects | Practice Guidelines as Topic | Prevention | Antiviral agents | Kidneys | Analysis | Immunotherapy | Organ transplant recipients | Cytomegalovirus infections | Dosage and administration | Rankings | Transplantation | T cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The gp130 Cytokine Interleukin‐11 Regulates Engraftment of Vav1–/– Hematopoietic Stem and Progenitor Cells in Lethally Irradiated Recipients
by De Vita, Serena and Li, Yanhua and Harris, Chad E and McGuinness, Meaghan K and Ma, Clement and Williams, David A
STEM CELLS, ISSN 1066-5099, 03/2018, Volume 36, Issue 3, pp. 446 - 457
During bone marrow transplantation, hematopoietic stem and progenitor cells (HSPCs) respond to signals from the hematopoietic microenvironment by coordinately... 
Hematopoietic progenitors | Hematopoiesis | Hematopoietic stem cells | Stem cells | EXCHANGE FACTOR | ACTIVATION | CYTOSKELETON | BONE-MARROW | RECEPTOR | PROLIFERATION | VAV1 | TRANSPLANTATION | CELL & TISSUE ENGINEERING | CELL BIOLOGY | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IN-VIVO | RHO GTPASES | HEMATOLOGY | Proto-Oncogene Proteins c-vav - genetics | Cytokine Receptor gp130 - metabolism | Cell Proliferation - physiology | Hematopoiesis - genetics | Hematopoietic Stem Cells - metabolism | Stem Cells - metabolism | Interleukin-11 - pharmacology | Hematopoiesis - drug effects | Animals | Stem Cells - drug effects | Stem Cells - physiology | Cell Proliferation - drug effects | Mice | Proto-Oncogene Proteins c-vav - metabolism | Bone marrow | Transplantation | G proteins | Interleukins | Cytokines | Fetuses | Interleukin | Radiation | Bone marrow transplantation | Irradiated | Stem cell transplantation | Ontogeny | Inflammation | Tissues | Progenitor cells | Hemopoiesis | Allografts | Pathways | Clonal deletion | Cells (biology) | Deletion | Irradiation | Glycoprotein gp130
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Liver transplantation for hepatitis C virus (HCV) non‐viremic recipients with HCV viremic donors
by Kwong, Allison J and Wall, Anji and Melcher, Marc and Wang, Uerica and Ahmed, Aijaz and Subramanian, Aruna and Kwo, Paul Y
American Journal of Transplantation, ISSN 1600-6135, 05/2019, Volume 19, Issue 5, pp. 1380 - 1387
In the context of organ shortage, the opioid epidemic, and effective direct‐acting antiviral ( DAA ) therapy for hepatitis C virus ( HCV ), more HCV ‐infected... 
liver allograft function/dysfunction | organ acceptance | liver disease | liver transplantation/hepatology | clinical research/practice | SURGERY | MANAGEMENT | GRAFTS | SOFOSBUVIR | RISK | POSITIVE DONORS | TRANSPLANTATION | INFECTION | SOCIETY CONSENSUS STATEMENT | Antiviral agents | Liver | Medical records | Organ transplant recipients | Transplantation | Nucleic acids | Hepatitis C virus | Health aspects | Hepatitis | Allografts | Transplants & implants | Donors | Syngeneic grafts | Opioids | Hepatitis C | Liver transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Transplanting hepatitis C virus–infected hearts into uninfected recipients: A single‐arm trial
by McLean, Rhondalyn C and Reese, Peter P and Acker, Michael and Atluri, Pavan and Bermudez, Christian and Goldberg, Lee R and Abt, Peter L and Blumberg, Emily A and Van Deerlin, Vivianna M and Reddy, K. Rajender and Bloom, Roy D and Hasz, Richard and Suplee, Lawrence and Sicilia, Anna and Woodards, Ashley and Zahid, Muhammad Nauman and Bar, Katharine J and Porrett, Paige and Levine, Matthew H and Hornsby, Nicole and Gentile, Caren and Smith, Jennifer and Goldberg, David S
American Journal of Transplantation, ISSN 1600-6135, 09/2019, Volume 19, Issue 9, pp. 2533 - 2542
The advent of direct‐acting antiviral therapy for hepatitis C virus ( HCV ) has generated tremendous interest in transplanting organs from HCV ‐infected... 
heart failure/injury | heart (allograft) function/dysfunction | organ transplantation in general | clinical research/practice | organ procurement and allocation | infection and infectious agents ‐ viral | heart transplantation/cardiology | organ allocation | infection and infectious agents - viral | SEROPOSITIVITY | SURGERY | heart failure | practice | heart transplantation | CARDIAC ALLOGRAFT VASCULOPATHY | SOFOSBUVIR | RISK | RIBAVIRIN | cardiology | LEDIPASVIR | dysfunction | TRANSPLANTATION | VELPATASVIR | THERAPY | heart (allograft) function | clinical research | PEGINTERFERON ALPHA-2B | HCV | injury | Heart | Antiviral agents | Corporate sponsorship | Transplantation | Hepatitis C virus | Health aspects | Hepatitis | Liver diseases | Donors | Heart transplantation | Interferon | Ventricle | Ribonucleic acid--RNA | Hepatitis C | Genotypes | Graft rejection
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged‐Release Tacrolimus Regimens—The DIAMOND Study
by TruneČka, P and Klempnauer, J and Bechstein, W. O and Pirenne, J and Friman, S and Zhao, A and Isoniemi, H and Rostaing, L and Settmacher, U and Mönch, C and Brown, M and Undre, N and Tisone, G and DIAMOND Study Grp and DIAMOND† study group
American Journal of Transplantation, ISSN 1600-6135, 07/2015, Volume 15, Issue 7, pp. 1843 - 1854
The DIAMOND study demonstrates that an initial lower dose or a delayed higher dose of prolonged‐release tacrolimus significantly reduces renal function... 
clinical trial | liver allograft function/dysfunction | calcineurin inhibitor | immunosuppression/immune modulation | liver transplantation: split | clinical research/practice | tacrolimus | glomerular filtration rate (GFR) | immunosuppressant | liver transplantation/hepatology | SURGERY | REDUCED-DOSE TACROLIMUS | TRANSPLANTATION | Graft Rejection - drug therapy | Liver Transplantation | Glomerular Filtration Rate | Prognosis | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Risk Factors | Male | Kidney Function Tests | Tacrolimus - therapeutic use | Graft Survival - physiology | Liver - physiology | Female | Liver Diseases - surgery | Liver Diseases - physiopathology | Graft Rejection - pathology | Postoperative Complications | Medical research | Corticosteroids | Tacrolimus | Liver | Medicine, Experimental | Organ transplant recipients | Transplantation | Mycophenolate mofetil | Transplants & implants | Side effects | practice | hepatology | immunosuppression | dysfunction | clinical research | immune modulation | liver allograft function | Original | liver transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Comparing Scientific Registry of Transplant Recipients posttransplant program‐specific outcome ratings at listing with subsequent recipient outcomes after transplant
by Wey, Andrew and Salkowski, Nicholas and Kasiske, Bertram L and Skeans, Melissa and Schaffhausen, Cory R and Gustafson, Sally K and Israni, Ajay K and Snyder, Jon J
American Journal of Transplantation, ISSN 1600-6135, 02/2019, Volume 19, Issue 2, pp. 391 - 398
To improve accessibility of program‐specific reports to patients, the Scientific Registry of Transplant Recipients released a 5‐tier system for categorizing... 
organ transplantation in general | Scientific Registry for Transplant Recipients (SRTR) | health services and outcomes research | statistics | SURGERY | REGULATORY OVERSIGHT | QUALITY | ASSOCIATION | TRANSPLANTATION | Heart | Medicine, Experimental | Organ transplant recipients | Medical research | Transplantation | Liver | Allografts | Kidneys | Syngeneic grafts | Heart transplantation | Lung transplantation | Risk factors | Liver transplantation | Kidney transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Histoplasmosis in transplant recipients
by Gajurel, Kiran and Dhakal, Reshika and Deresinski, Stan
Clinical Transplantation, ISSN 0902-0063, 10/2017, Volume 31, Issue 10, pp. e13087 - n/a
Histoplasma capsulatum is a dimorphic fungus that most often causes asymptomatic infection in the immunocompetent population. In immunocompromised patients,... 
transplant | itraconazole | hematopoietic | antigen | histoplasma | SURGERY | RENAL-ALLOGRAFT RECIPIENTS | HEMOPHAGOCYTIC SYNDROME | PULMONARY HISTOPLASMOSIS | INVASIVE FUNGAL-INFECTIONS | SOLID-ORGAN TRANSPLANT | GALACTOMANNAN ASSAY | TRANSPLANTATION | SURVEILLANCE NETWORK TRANSNET | BONE-MARROW TRANSPLANT | STEM-CELL TRANSPLANT | CUTANEOUS HISTOPLASMOSIS | Histoplasmosis - etiology | Transplant Recipients | Humans | Organ Transplantation - adverse effects | Transplantation of organs, tissues, etc | Organ transplant recipients | Histoplasmosis | Transplantation | Hematopoietic stem cells
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (DSA)
by Loupy, A and Hill, G. S and Suberbielle, C and Charron, D and Anglicheau, D and Zuber, J and Timsit, M. O and Duong, J. P and Bruneval, P and Vernerey, Dewi and Empana, J. P and Jouven, X and Nochy, D and Legendre, C. H
American Journal of Transplantation, ISSN 1600-6135, 01/2011, Volume 11, Issue 1, pp. 56 - 65
The significance of C4d‐Banff scores in protocol biopsies of kidney transplant recipients with preformed donor‐specific antibodies (DSA) has not been... 
donor‐specific antibodies | Chronic graft deterioration | humoral allograft rejection | donor-specific antibodies | SURGERY | DEPOSITION | HISTOLOGIC-FINDINGS | INJURY | CLASSIFICATION | ALLOANTIBODY | MEDIATED REJECTION | TRANSPLANTATION | RENAL-ALLOGRAFT REJECTION | ACUTE HUMORAL REJECTION | POSITIVE CROSS-MATCH | PERITUBULAR CAPILLARY C4D | Complement C4b - immunology | Graft Survival - immunology | Kidney Transplantation - pathology | Humans | Middle Aged | Kidney - immunology | Antibodies | Biopsy | Peptide Fragments - immunology | Adult | Aged | Microcirculation - immunology | Graft Rejection - immunology | Kidney Transplantation - immunology | Viral antibodies | Organ transplant recipients | Transplantation | Kidneys | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Cancer and mTOR Inhibitors in Transplant Recipients
by de Fijter, Johan W
Transplantation, ISSN 0041-1337, 02/2018, Volume 102, Issue 2S Suppl 1, pp. S60 - S70
ABSTRACTMalignancy is the second most common single cause of death observed in organ transplant recipients. The excess cancer risk is related to intensity and... 
SOLID-ORGAN TRANSPLANTATION | SURGERY | RENAL-ALLOGRAFT RECIPIENTS | IMMUNOLOGY | TRANSPLANTATION | PHASE-II TRIAL | TUBEROUS SCLEROSIS COMPLEX | NONMELANOMA SKIN-CANCER | KAPOSIS-SARCOMA | POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS | KIDNEY-TRANSPLANTATION | SQUAMOUS-CELL CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | TOR Serine-Threonine Kinases - metabolism | Tumor Virus Infections - virology | Humans | Immunosuppressive Agents - therapeutic use | Neoplasms - prevention & control | Protein Kinase Inhibitors - adverse effects | TOR Serine-Threonine Kinases - antagonists & inhibitors | Neoplasms - virology | Time Factors | Graft Rejection - mortality | Tumor Virus Infections - immunology | Anticarcinogenic Agents - adverse effects | Opportunistic Infections - immunology | Drug Therapy, Combination | Anticarcinogenic Agents - therapeutic use | Organ Transplantation - mortality | Graft Rejection - enzymology | Opportunistic Infections - virology | Graft Rejection - prevention & control | Risk Factors | Neoplasms - mortality | Treatment Outcome | Calcineurin Inhibitors - adverse effects | Animals | Signal Transduction - drug effects | Neoplasms - immunology | Protein Kinase Inhibitors - therapeutic use | Organ Transplantation - adverse effects | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Immunocompromised Host | Graft Survival - drug effects | Prevention | Transplantation of organs, tissues, etc | Physiological aspects | Enzyme inhibitors | Carcinogenesis | Patient outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
by Kamar, Nassim and Izopet, Jacques and Tripon, Simona and Bismuth, Michael and Hillaire, Sophie and Dumortier, Jérôme and Radenne, Sylvie and Coilly, Audrey and Garrigue, Valérie and D'Alteroche, Louis and Buchler, Matthias and Couzi, Lionel and Lebray, Pascal and Dharancy, Sebastien and Minello, Anne and Hourmant, Maryvonne and Roque-Afonso, Anne-Marie and Abravanel, Florence and Pol, Stanislas and Rostaing, Lionel and Mallet, Vincent
The New England Journal of Medicine, ISSN 0028-4793, 03/2014, Volume 370, Issue 12, pp. 1111 - 1120
Hepatitis E virus may cause chronic infection in certain patients, such as those who are immunocompromised. In this report from France involving 59 solid-organ... 
MEDICINE, GENERAL & INTERNAL | HIV-INFECTION | THERAPY | CELL RESPONSE | PATIENT | KIDNEY | PEGYLATED INTERFERON-ALPHA | VIROLOGICAL RESPONSE | ORGAN-TRANSPLANTATION | Virus Replication - drug effects | Hepatitis E - drug therapy | Drug Administration Schedule | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Male | Organ Transplantation | Viral Load | Hepatitis E virus - physiology | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Adult | Female | Aged | Retrospective Studies | Chronic Disease | Hepatitis E virus - isolation & purification | Complications and side effects | Hepatitis E | Transplantation of organs, tissues, etc | Dosage and administration | Drug therapy | Risk factors | Ribavirin | Enzymes | Kidneys | Transplants & implants | Erythropoietin | Viremia | Syngeneic grafts | Heart transplantation | Body weight | Lung transplantation | Chronic infection | Ribonucleic acid--RNA | Patients | Hepatitis | Hospitals | Allografts | Genotyping | Cell number | Pancreas transplantation | Genotypes | Liver transplantation | Kidney transplantation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights